Indeed, in inflammatory chronic conditions such as liver cirrhosis, idiopathic pulmonary fibrosis, and heart failure, IL-17 contributes to the severe fibrotic process through various mechanisms, including the induction of resident stromal cells and the progression of the inflammatory status. Here, IL17A is linked to idiopathic pulmonary fibrosis.